Pro-Dex, Inc.
PDEXHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. With a market capitalization of $201.2M, it sits in micro-cap territory. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Market Cap
$201.2M
Beta
0.04
P/E (TTM)
15.10
P/E (Fwd)
18.52
EPS (TTM)
$4.12
EPS (Fwd)
$3.36
ROE
32.4%
ROA
12.0%
Cash
$9.3M
Total Debt
$18.9M
Free CF
$5.4M
52W Change
115.5%
Annual Financials
Cash vs Debt
Where PDEX stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, PDEX finished 4.23% below its 150-day moving average ($60.25) and 3.72% above its 200-day moving average ($55.63). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PDEX overbought or oversold?
At the October 20, 2026 close, PDEX's RSI(14) was 14.1, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, PDEX has $9.3M in cash with $18.9M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $5.4M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 32.4%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 12.0% further supports the picture of efficient asset utilization. Revenue has grown from $46.1M (2023) to $77.5M (2026), reflecting a 68% increase over the period.
With a beta below 0.7, Pro-Dex, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing PDEX.